Ademi LLP is investigating Veracyte for potential securities fraud related to allegedly inaccurate statements about its financials and business prospects, particularly concerning its Decipher Prostate testing. This investigation follows a significant drop of more than 50% in Veracyte's stock price. Shareholders who have lost money are encouraged to contact Ademi LLP to discuss their rights. The outcome of this investigation could impact Veracyte's reputation and investor confidence moving forward.
Regarding the Veracyte securities fraud investigation, here is Pluang's health sector market snapshot as of Nov 06, 2026 05:11 WIB: Out of 150 priced US health stocks tradable on Pluang, 17 rose and 133 fell today. Notable movers include SELLAS Life Sciences Group Inc. (SLS) at USD 7.83 with a 1-day change of -14.39% and a typical hold time of 11 days, ClearPoint Neuro Inc. (CLPT) at USD 8.73 down 14.07% with a near-even Pluang order activity split and a 12-day hold time, and Nuwellis Inc. (NUWE) at USD 4.60 down 12.71% with 100% buy order activity and a 31-day typical hold time.
Strawberry Fields REIT announced a cash dividend of $0.17 per common share for the fourth quarter of 2026. The dividend will be paid on December 30, 2026, to shareholders recorded by December 16, 2026. The company specializes in owning and leasing he...
Globe Life Inc. announced a quarterly dividend of $0.33 per share for shareholders of record as of January 8, 2027. This dividend will be paid on February 1, 2027. Globe Life is a holding company focused on life and supplemental health insurance for ...
Volatus Aerospace Inc., a global aerospace and defence company, will announce its financial results for the third quarter and nine months ended September 30, 2026, on November 10, 2026, after market close. The company will host a webinar featuring it...
Cytek Biosciences' Cytek Aurora Evo system was named Drug Discovery Innovation of the Year in the 2026 BioTech Breakthrough Awards for its advanced spectral flow cytometry technology. The system offers higher throughput, automation, and reproducible ...
Quantum BioPharma filed a supplement to its management circular correcting the treatment of fractional shares in its proposed share consolidation. Fractions of shares will be rounded up or down based on size. The company also clarified that voting po...
